| Trial ID: | L4102 |
| Source ID: | NCT00110435
|
| Associated Drug: |
Mk0653a, Ezetimibe (+) Simvastatin
|
| Title: |
A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Hypercholesterolemia
|
| Interventions: |
DRUG: MK0653A, ezetimibe (+) simvastatin|DRUG: Duration of Treatment: 4 wk placebo run in then 6 wk active|DRUG: Comparator: atorvastatin
|
| Outcome Measures: |
Primary: Percent reduction in LDL-C from baseline after 6 weeks of treatment | Secondary: Percent of patients attaining LDL-C <70 mg/dl after 6 weeks of treatment
|
| Sponsor/Collaborators: |
Sponsor: Organon and Co
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
1229
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2005-05
|
| Completion Date: |
2005-12
|
| Results First Posted: |
|
| Last Update Posted: |
2024-08-15
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00110435
|
